These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9403719)

  • 1. NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
    Sirica AE; Radaeva S; Caran N
    Am J Pathol; 1997 Dec; 151(6):1685-94. PubMed ID: 9403719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of C-NEU and C-MET during rat liver cholangiocarcinogenesis: A link between biliary intestinal metaplasia and mucin-producing cholangiocarcinoma.
    Radaeva S; Ferreira-Gonzalez A; Sirica AE
    Hepatology; 1999 May; 29(5):1453-62. PubMed ID: 10216129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
    Elmore LW; Sirica AE
    Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.
    Lai GH; Radaeva S; Nakamura T; Sirica AE
    Hepatology; 2000 Jun; 31(6):1257-65. PubMed ID: 10827151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
    Hughes NR; Goodman ZD; Bhathal PS
    Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary proliferation and adaptation in furan-induced rat liver injury and carcinogenesis.
    Sirica AE
    Toxicol Pathol; 1996; 24(1):90-9. PubMed ID: 8839286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
    Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
    Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis.
    Terada T; Nakanuma Y; Sirica AE
    Hum Pathol; 1998 Feb; 29(2):175-80. PubMed ID: 9490278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma.
    Terada T; Ashida K; Endo K; Horie S; Maeta H; Matsunaga Y; Takashima K; Ohta T; Kitamura Y
    Histopathology; 1998 Oct; 33(4):325-31. PubMed ID: 9822921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new rat bile ductular epithelial cell culture model characterized by the appearance of polarized bile ducts in vitro.
    Sirica AE; Gainey TW
    Hepatology; 1997 Sep; 26(3):537-49. PubMed ID: 9303480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats.
    Elmore LW; Sirica AE
    Hepatology; 1992 Nov; 16(5):1220-6. PubMed ID: 1427660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell kinetic analyses and expression of carcinoembryonic antigen, carbohydrate antigen 19-9 and DU-PAN-2 in hyperplastic, pre-neoplastic and neoplastic lesions of intrahepatic bile ducts in livers with hepatoliths.
    Terada T; Nakanuma Y
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):327-35. PubMed ID: 1348889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of albumin and alpha-fetoprotein mRNAs in normal, hyperplastic, and preneoplastic rat liver.
    Alpini G; Aragona E; Dabeva M; Salvi R; Shafritz DA; Tavoloni N
    Am J Pathol; 1992 Sep; 141(3):623-32. PubMed ID: 1381559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of an intestine-specific transcription factor (CDX1) in intestinal metaplasia and in subsequently developed intestinal type of cholangiocarcinoma in rat liver.
    Ren P; Silberg DG; Sirica AE
    Am J Pathol; 2000 Feb; 156(2):621-7. PubMed ID: 10666391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
    Bristol DW
    Toxic Rep Ser; 2011 Jan; (82):1-111. PubMed ID: 21445103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
    Lee KT; Liu TS
    Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes.
    Hughes NR; Pairojkul C; Royce SG; Clouston A; Bhathal PS
    J Clin Pathol; 2006 Oct; 59(10):1073-8. PubMed ID: 16679351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary neoplasm arising from peribiliary glands connecting with the inferior branch of the bile duct of the anterior segment of the liver.
    Nakanishi Y; Nakanuma Y; Ohara M; Iwao T; Kimura N; Ishidate T; Kijima H
    Pathol Int; 2011 Dec; 61(12):773-7. PubMed ID: 22126388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
    Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
    J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor and HER-2/neu status by immunohistochemistry and fluorescence in situ hybridization in adenocarcinomas of the biliary tree and gallbladder.
    Shafizadeh N; Grenert JP; Sahai V; Kakar S
    Hum Pathol; 2010 Apr; 41(4):485-92. PubMed ID: 20040392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.